Der er givet ugentlige doser op til 540 og 630 mikrogram i studier om renalcellekarcinom og kronisk myeloid leukæmi.
Weekly doses of up to 540 and 630 micrograms have been administered in renal cell carcinoma and chronic myelogenous leukaemia clinical trials, respectively.